Sleep · Brain health technique
Lower-risk sleep medications
Evidence grade: Context Dependent
Safer, better-studied prescription options that can support sleep onset or maintenance when behavioral and environmental measures aren’t sufficient. Includes melatonin agonists (ramelteon), low-dose tricyclics (doxepin ≤6 mg), orexin antagonists (suvorexant, lemborexant), and low-dose sedating antidepressants (trazodone).
- Practice
- Sleep
- Principle
- Restoration
- Tactic
- Medication And Supplements
- Evidence grade
- Context Dependent
- Strength of evidence
- Medium
How to practice Lower-risk sleep medications
Use only after behavioral interventions (sleep hygiene, CBT-I) have failed or are insufficient. Start at the lowest effective dose under medical supervision. Avoid combining multiple sedatives or alcohol. Reassess regularly; aim for the shortest effective course (weeks to months).
The evidence behind Lower-risk sleep medications
These agents target specific sleep-regulation pathways (melatonin, orexin, histamine) with lower dependence potential than older hypnotics. RCTs show modest but reliable improvements in sleep onset and maintenance. Benefits mainly in chronic insomnia unresponsive to CBT-I. Risks include next-day grogginess or rare parasomnias, depending on the compound. Long-term safety generally favorable with proper dosing.
More Sleep techniques
Take control of your brain health
BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.